ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹5,902 Cr | ₹5,178 Cr | ₹4,539 Cr | ₹4,207 Cr | ₹3,823 Cr |
What is the latest Total Liabilities ratio of ABBOTT INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹5,902 Cr |
| Mar2024 | ₹5,178 Cr |
| Mar2023 | ₹4,539 Cr |
| Mar2022 | ₹4,207 Cr |
| Mar2021 | ₹3,823 Cr |
How is Total Liabilities of ABBOTT INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,902 Cr | 14.00 | |
| Mar2024 | ₹5,178 Cr | 14.08 | |
| Mar2023 | ₹4,539 Cr | 7.88 | |
| Mar2022 | ₹4,207 Cr | 10.06 | |
| Mar2021 | ₹3,823 Cr | - | |
Compare Total Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹56,866.2 Cr | 2% | 2.1% | -16% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,889.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 2% |
2.1% |
-16% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses